Truveta, Inc.
From EverybodyWiki Bios & Wiki
| Private | |
| ISIN | 🆔 |
| Industry | Health technology |
| Founded 📆 | 2020 |
| Founder 👔 | |
Area served 🗺️ | |
Key people | Terry Myerson, CEO |
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
Truveta, Inc., headquartered in Bellevue, Washington, USA, is an American healthcare data and analytics company owned and governed by 30 U.S. health systems with a mission of "Saving Lives with Data"[1].
Established in September 2020, the company was initially founded by Providence, Advocate Health, Tenet Health, and Trinity Health. The company was formally announced in February 2021 with 14 health system members[2]. As of 2025, Truveta has 30 U.S. member health systems.
Using AI, Truveta provides de-identified electronic health record data—linked with closed claims—for more than 120 million US patients to advance medical research and innovation. Truveta operates in the US healthcare market, collaborating with health systems, life sciences, academic and research, and government organizations to provide data-driven insights to improve patient care and outcomes.
Today, Truveta membership includes Providence, Advocate Health, Trinity Health, Tenet Healthcare, Northwell Health, AdventHealth, Baptist Health of Northeast Florida, Baylor Scott & White Health, Bon Secours Mercy Health, CommonSpirit Health, Hawaii Pacific Health, HealthPartners, Henry Ford Health System, HonorHealth, Inova, Lehigh Valley Health Network, MedStar Health, Memorial Hermann Health System, MetroHealth, Novant Health, Ochsner Health, Premier Health, Saint Luke’s Health System, Sanford Health, Sentara Healthcare, Texas Health Resources, TriHealth, UnityPoint Health, Virtua Health, and WellSpan Health.
History
- September 2020: Truveta was formed in September 2020 by a collective of US health systems with a mission of Saving Lives with Data. Formally announced in February 2021[3], Truveta's initial membership included 14 health[4] systems: AdventHealth, Advocate Aurora Health, Baptist Health of Northeast Florida, Bon Secours Mercy Health, CommonSpirit Health, Hawaii Pacific Health, Henry Ford Health System, Memorial Hermann Health System, Northwell Health, Novant Health, Providence, Sentara Healthcare, Tenet Health, and Trinity Health.
- September 2021: Truveta and Microsoft form partnership[5]
- November 2021:First product announcement and insights from the data[6]
- June 2022: First customer announcement – Pfizer[7][8]
- September 2022: Second customer announcement – Boston Scientific[9][10]
- April 2023: Truveta announces the Truveta Language Model[11][12], its award-winning[13] large-language, multi-modal AI model for transforming electronic health record (EHR) data into billions of clean and accurate data points for health research on any drug, disease, or device.
- January 2025: Truveta announces the Truveta Genome Project[14][15] in collaboration with its health system members, Regeneron, Illumina, and Microsoft; announces $320M in Series C funding.
Awards
- 2022 Fast Company World Changing Ideas - Honorable Mention in AI and Data, Health[16][17]
- 2022 GeekWire Awards - Health Innovation of the Year[18]
- 2023 LinkedIn Top Startups[19]
- 2024 Gold Stevie Award - Achievement in Science of Technology - Up to 2,500 employees[20]
- 2024 Silver Stevie Award - Most Innovative Company of the Year - Up to 2,500 employees[21]
- 2024 Best in Biz Awards - Gold - Most Innovative Company of the Year - Medium[22][23]
- 2024 South by Southwest Innovation Award - Artificial Intelligence[24][25]
- 2024 LinkedIn Top Startups[26]
- 2024 LinkedIn Top Startups in Seattle[27]
- 2025 GeekWire Awards - Next Tech Titan[28]
- 2025 LinkedIn Top Startups[29]
- 2025 LinkedIn Top Startups in Seattle[30]
Research using Truveta Data
- A 2023 study published in JAMA Network Open examined changes in prescribing patterns of oral minoxidil for hair loss after media attention, using prescription data from U.S. health-system records, including those affiliated with Truveta.[31]
- A 2023 study published in Vaccine assessed the risk of COVID-19 breakthrough infection and hospitalization among individuals with comorbidities using data from U.S. health-system records, including those from Truveta-affiliated systems.[32]
- A 2023 preprint titled Truveta Mapper: A Zero-shot Ontology Alignment Framework presented a methodology for aligning biomedical ontologies using zero-shot learning — a tool that could support data interoperability for health systems working with Truveta data.[33]
- A 2023 real-world, big-data analysis published in Journal of the Society for Cardiovascular Angiography & Interventions compared ultrasound-assisted catheter-directed therapy (USCDT) versus medical therapy for pulmonary embolism (REAL-PE), based on data drawn from Truveta-affiliated health systems.[34]
- A 2023 study published in Frontiers in Public Health evaluated racial inequalities in COVID-19 treatment and in-hospital length of stay in the United States over time, using data derived from large health-system datasets including those affiliated with Truveta.[35]
- A 2023 time-series study published in JAMA Pediatrics examined first-time pediatric speech delay incidence from 2018 to 2022 using data from U.S. health systems, including those affiliated with Truveta.[36]
- A 2024 real-world big-data analysis published in Journal of the Society for Cardiovascular Angiography & Interventions compared ultrasound-assisted catheter-directed therapy (USCDT) versus standard medical therapy for pulmonary embolism (REAL-PE), using data derived from large U.S. health-system records, including those affiliated with Truveta.[37]
- A 2024 cohort study published in JACC: Heart Failure evaluated decongestion strategies in patients hospitalized for heart failure using a large, community-based dataset including records from Truveta-affiliated health systems.[38]
- A 2024 study published in JAMA Internal Medicine compared the effectiveness of semaglutide versus tirzepatide for weight loss in adults with overweight or obesity, using data from Truveta-affiliated health systems.[39]
- A 2024 study published in The American Journal of Gastroenterology examined real-world adherence to repeat stool-based colorectal cancer screening using fecal immunochemical tests (FIT) and multi-target stool DNA tests (mt-sDNA). Because these non-invasive tests require repeated use at regular intervals to be effective, the researchers analyzed patterns of repeat testing and evaluated factors associated with adherence. [40]
- A 2025 study published in JAMA Network Open examined patterns of discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among U.S. adults with overweight or obesity using Truveta data.[41]
- A 2025 study published in the American Journal of Preventive Medicine analyzed trends in syphilis incidence among U.S. adults from 2017 to 2024 using Truveta Data.[42]
- A 2025 retrospective evaluation published in a peer-reviewed medical journal analyzed non-tunneled hemodialysis catheters — assessing design features, associated risks, and usage trends of dual- and triple-lumen devices based on real-world data.[43]
- A 2025 study published in Pediatrics Open Science examined changes in pediatric obesity treatment practices in the United States following updated guidelines from the American Academy of Pediatrics, using data from large health-system records, including those affiliated with Truveta.[44]
- A 2025 study published in a peer-reviewed journal explored structured large language model (LLM) augmentation for clinical information extraction, assessing its performance and potential for healthcare data analysis.[45]
- A 2025 real-world analysis published in Journal of Cardiac Failure evaluated survival outcomes associated with cardiac contractility modulation devices, using cardiac resynchronization therapy data to validate methodological approaches with large U.S. health-system records, including those from Truveta-affiliated systems.[46]
- A 2025 real-world analysis published in Journal of Cardiac Failure evaluated survival outcomes associated with cardiac contractility modulation, using cardiac resynchronization therapy data from a large U.S. health-system cohort including Truveta-affiliated records.[47]
- A 2025 study published in Journal of Endourology / Urology & Nephrology Clinics compared postoperative infection rates for patients using a single-use ureteroscope with real-time intrarenal pressure monitoring versus other single-use ureteroscopes in a clinical setting using large health-system data.[48]
- A 2025 study published in Sexually Transmitted Diseases assessed the need for creating ICD-10 codes to improve monitoring of doxycycline postexposure prophylaxis prescriptions in the United States.[49]
- A 2025 study published in Radiology Advances developed “XComposition,” a multimodal deep-learning model that uses chest radiographs and clinical data to estimate body composition, demonstrating a novel application of large health-system data for medical imaging research.[50]
References
- ↑ , (2021-02-24). "Truveta data expands beyond EHR". Yahoo Finance.
- ↑ Boss, Dina; Tozzi, John (2021-02-11). "Startup Truveta links U.S. health systems to share patient data". Bloomberg.
- ↑ Mathews, Anna Wilde (2021-02-11). "Major Hospitals Form Company to Capitalize on Their Troves of Health Data". The Wall Street Journal. Retrieved 2025-12-03.
- ↑ Boss, Dina; Tozzi, John (2021-02-11). "Startup Truveta links U.S. health systems to share patient data". Bloomberg.
- ↑ Miliard, Mike (2021-09-30). "Truveta, Microsoft form cloud AI partnership with strategic investment". Healthcare IT News. Retrieved 2025-12-03.
- ↑ Schubert, Charlotte (2021-10-11). "Healthcare-data startup Truveta showcases new platform, now raised close to $200M". GeekWire. Retrieved 2025-12-03.
- ↑ Wu, Lei Lei (2022-06-21). "Big data meets Big Pharma: Pfizer buys real-time patient results in collaboration with Truveta". Endpoints News. Retrieved 2025-12-03.
- ↑ Schubert, Charlotte (2022-06-21). "Health data company Truveta to partner with Pfizer on monitoring COVID vaccines and therapies". GeekWire. Retrieved 2025-12-03.
- ↑ Diller, Wendy (2022-11-17). "Truveta and Boston Scientific Strive for the Ultimate in Data Sharing: Speed, Accuracy, and Privacy". MedTech Strategist. Retrieved 2025-12-03.
- ↑ Kennedy, Shania (2022-09-28). "Data Collaboration Aims to Improve Long-Term Patient Care, Health Disparities". TechTarget xtelligent Healthtech Analytics. Retrieved 2025-12-03.
- ↑ Lampton, Ellie (2023-04-12). "Announcing the Truveta Language Model". Truveta. Retrieved 2025-12-03.
- ↑ Schubert, Charlotte (2023-04-13). "This AI understands doctors' notes: Truveta's new model finds meaning in messy healthcare data". GeekWire. Retrieved 2025-12-03.
- ↑ "2024 SXSW Innovation Awards Winners Announced". SXSW. 2024. Retrieved 2025-12-03.
- ↑ Leake, Lindsey (2025-01-16). "Truveta genome project teams with Regeneron and Illumina to sequence US health-system patients". Fortune. Retrieved 2025-12-03.
- ↑ Niasse, Amina (2025-01-13). "Truveta sells stakes in Regeneron-Illumina deal to help build genetic database". Reuters. Retrieved 2025-12-03.
- ↑ Truveta staff (2022-05-03). "Truveta recognized by Fast Company's World Changing Ideas 2022". Truveta. Retrieved 2025-12-03.
- ↑ Fast Company Staff (2022-05-03). "These companies are using AI and data to empower positive change". Fast Company. Retrieved 2025-12-03.
- ↑ Schubert, Charlotte (2022-04-12). "Health Innovation of the Year: 5 finalists at the GeekWire Awards span fields and approaches". GeekWire. Retrieved 2025-12-03.
- ↑ Bell, Juliette (Faraut) (2023-09-27). "LinkedIn Top Startups 2023: The 50 U.S. companies on the rise". LinkedIn News. Retrieved 2025-12-03.
- ↑ Truveta staff (2024-04-25). "Truveta wins 2024 Stevie Awards for Most Innovative Company and Achievement in Technology". Truveta. Retrieved 2025-12-03.
- ↑ Truveta staff (2024-04-25). "Truveta wins 2024 Stevie Awards for Most Innovative Company and Achievement in Technology". Truveta. Retrieved 2025-12-03.
- ↑ Truveta staff (2024-07-23). "Truveta named a winner in Best in Biz Awards 2024 for Innovation". Truveta. Retrieved 2025-12-03.
- ↑ Best in Biz Awards (2024). "2024 Winners: Company Categories". Best in Biz Awards. Retrieved 2025-12-03.
- ↑ SXSW staff (2024-03-11). "2024 SXSW Innovation Awards Winners Announced". SXSW. Retrieved 2025-12-03.
- ↑ Truveta staff (2024-10-22). "Truveta launches first-of-its-kind large language model for health care data collaboration". Truveta. Retrieved 2025-12-03.
- ↑ Bell, Juliette (Faraut) (2024-09-19). "The 50 Best U.S. Startups to Watch in 2024". LinkedIn News. Retrieved 2025-12-03.
- ↑ Bell, Juliette (Faraut) (2024-10-09). "LinkedIn Top Startups 2024: The 10 companies on the rise in Seattle". LinkedIn News. Retrieved 2025-12-03.
- ↑ Schlosser, Kurt (2025-03-10). "Next Tech Titan: Echodyne, Pulumi, Read AI, Statsig and Truveta in line for GeekWire Award". GeekWire. Retrieved 2025-12-03.
- ↑ Bell, Juliette (Faraut) (2025-10-15). "LinkedIn Top Startups 2025: The 50 U.S. companies on the rise". LinkedIn News. Retrieved 2025-12-03.
- ↑ Bell, Juliette (Faraut) (2025-10-15). "LinkedIn Top Startups 2025: The 10 companies on the rise in Seattle". LinkedIn News. Retrieved 2025-12-03.
- ↑ Goodwin Cartwright, Brianna M.; Wang, Michael; Rodriguez, Patricia; Stewart, Sarah; Worsham, Christopher M.; Stucky, Nick; Jena, Anupam B. (2023-05-09). "Changes in Minoxidil Prescribing After Media Attention About Oral Use for Hair Loss". JAMA Network Open. 6 (5): e2312477. doi:10.1001/jamanetworkopen.2023.12477. PMC 10170338 Check
|pmc=value (help). PMID 37159202 Check|pmid=value (help). - ↑ Smits, Peter D.; Gratzl, Samuel; Simonov, Michael; Nachimuthu, Senthil K.; Goodwin Cartwright, Brianna M.; Wang, Michael D.; Baker, Charlotte; Rodriguez, Patricia; Bogiages, Mackenzie; Althouse, Benjamin M.; Stucky, Nicholas L. (2023-03-29). "Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities". Vaccine. 41 (15): 2447–2455. doi:10.1016/j.vaccine.2023.02.038. PMC 9933320 Check
|pmc=value (help). PMID 36803895 Check|pmid=value (help). - ↑ Amir, Mariyam; Baruah, Murchana; Eslamialishah, Mahsa; Ehsani, Sina; Bahramali, Alireza; Naddaf-sh, Sadra; Zarandioon, Saman (2023-01-24). "Truveta Mapper: A Zero-shot Ontology Alignment Framework". arXiv. arXiv:2301.09767. Unknown parameter
|s2cid=ignored (help) - ↑ Monteleone, Peter; Ahern, Ryan A.; Banerjee, Subhash; Desai, Kush R.; Kadian-Dodov, Daniella; Webber, Emily; Omidvar, Sally; Troy, Patrick; Parikh, Sahil A. (2023-10-24). "Modern Treatment of Pulmonary Embolism (USCDT vs MT): Results From a Real-World, Big Data Analysis (REAL-PE)". Journal of the Society for Cardiovascular Angiography & Interventions. 3 (1). doi:10.1016/j.jscai.2023.101192. PMC 11308131 Check
|pmc=value (help). PMID 39131982 Check|pmid=value (help). Retrieved 2025-12-03. Unknown parameter|article-number=ignored (help) - ↑ Althouse, Benjamin M.; Baker, Charlotte; Smits, Peter D.; Gratz, Samuel; Lee, Ryan H.; Goodwin Cartwright, Brianna M.; Simonov, Michael; Wang, Michael D.; Stucky, Nicholas L. (2023-01-10). "Racial inequality in COVID-treatment and in-hospital length of stay in the US over time". Frontiers in Public Health. 10. Bibcode:2023FrPH...1074775A. doi:10.3389/fpubh.2022.1074775. PMC 9876573 Check
|pmc=value (help). PMID 36711416 Check|pmid=value (help). Unknown parameter|article-number=ignored (help) - ↑ Goodwin Cartwright, Brianna M.; Smits, Peter D.; Stewart, Sarah (2023-12-04). "Time-Series Analysis of First-Time Pediatric Speech Delays From 2018 to 2022". JAMA Pediatrics. 178 (2): 193–195. doi:10.1001/jamapediatrics.2023.5226. PMC 10696512 Check
|pmc=value (help). PMID 38048098 Check|pmid=value (help). - ↑ Monteleone, Peter; Ahern, Ryan A.; Banerjee, Subhash; Desai, Kush R.; Kadian-Dodov, Daniella; Webber, Emily; Omidvar, Sally; Troy, Patrick; Parikh, Sahil A. (2024-01-01). "Modern Treatment of Pulmonary Embolism (USCDT vs MT): Results From a Real-World, Big Data Analysis (REAL-PE)". Journal of the Society for Cardiovascular Angiography & Interventions. 3 (1). doi:10.1016/j.jscai.2023.101192. Retrieved 2025-12-03. Unknown parameter
|article-number=ignored (help) - ↑ Zheng, Jimmy; Ambrosy, Andrew P.; Bhatt, Ankeet S.; Collins, Sean P.; Flint, Kelsey M.; Fonarow, Gregg C.; Fudim, Marat; Greene, Stephen J.; Lala, Anuradha; Testani, Jeffrey M.; Varshney, Anubodh S.; Wi, Ryan S.K.; Sandhu, Alexander T. (2024-04-07). "Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study". JACC: Heart Failure. 12 (8). doi:10.1016/j.jchf.2024.04.002. PMID 38678466 Check
|pmid=value (help). Retrieved 2025-12-03. - ↑ Rodriguez, Patricia J.; Goodwin Cartwright, Brianna M.; Gratzl, Samuel (2024-07-08). "Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity". JAMA Internal Medicine. 184 (9): 1056–1064. doi:10.1001/jamainternmed.2024.2525. PMC 11231910 Check
|pmc=value (help). PMID 38976257 Check|pmid=value (help). - ↑ Shaukat, Aasma; Liao, Jiemin; Saha, Jayati; Forbes, Shaun P.; Watkins, Angela; Zhang, Nicole J.; Raymond, Victoria M.; Das, Amarendra; Eagle, Craig; Talasaz, AmirAli (2024-10-01). "S375 Real-World Adherence to Repeat Testing for Stool-Based Non-Invasive Colorectal Cancer Screening Tests Among Individuals With Average Risk". The American Journal of Gastroenterology. 119 (10S): S265–S266. doi:10.14309/01.ajg.0001030868.43296.05. Retrieved 2025-12-03.
- ↑ Rodriguez, Patricia J.; Zhang, Vincent; Gratzl, Samuel (2025-01-31). "Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity". JAMA Network Open. 8 (1): e2457349. doi:10.1001/jamanetworkopen.2024.57349. PMC 11786232 Check
|pmc=value (help). PMID 39888616 Check|pmid=value (help). - ↑ Do, Duy; Rodriguez, Patricia J.; Gratzl, Samuel; Goodwin Cartwright, Brianna M.; Baker, Charlotte; Stucky, Nicholas L. (2025-04-01). "Trends in Incidence of Syphilis Among US Adults from January 2017 to October 2024". American Journal of Preventive Medicine. doi:10.1016/j.amepre.2025.03.008. PMID 40185421 Check
|pmid=value (help). Retrieved 2025-12-03. - ↑ Miller, George; Zabaleta, Isabella; Ogujiofor, Kingsley; Fatima, Rukhaiya; Albrecht, Emma; Warden, Madalyn (2025-07-02). "Design features, associated risks, and usage trends of non-tunneled hemodialysis catheters: A retrospective evaluation of dual and triple lumen devices". The International Journal of Artificial Organs. doi:10.1177/11297298251352470. PMID 40605326 Check
|pmid=value (help). - ↑ Rodriguez, Patricia J.; Do, Duy; Gratzl, Samuel; Goodwin-Cartwright, Brianna M.; Stucky, Nicholas L.; Wright, Davene R. (2025-08-01). "Shifts in US Pediatric Obesity Treatment After the AAP Guidelines". Pediatrics Open Science. 1 (3): 1–12. doi:10.1542/pedsos.2025-000623. Retrieved 2025-12-03.
- ↑ Wei, Ying; Li, Qi; Pillai, Jay (2025-08-07). "Structured LLM Augmentation for Clinical Information Extraction". Studies in Health Technology and Informatics. 329: 971–976. doi:10.3233/SHTI250984. ISBN 978-1-64368-608-0. PMID 40776002 Check
|pmid=value (help). - ↑ Sauer, Andrew J.; Hass, Ryan; Cranke, Gary; Burkhoff, Daniel; Rao, Ishu (2025-09-01). "Real-World Survival Outcomes With Cardiac Contractility Modulation: Methodological Validation Using Cardiac Resynchronization Therapy Data". Journal of Cardiac Failure. 31 (9): 1490–1492. doi:10.1016/j.cardfail.2025.08.009. PMC 12661499 Check
|pmc=value (help). PMID 41233031 Check|pmid=value (help). Retrieved 2025-12-03. Unknown parameter|pmc-embargo-date=ignored (help) - ↑ Sauer, Andrew J.; Hass, Ryan; Cranke, Gary; Burkhoff, Daniel; Rao, Ishu (2025-09-01). "Real-World Survival Outcomes With Cardiac Contractility Modulation: Methodological Validation Using Cardiac Resynchronization Therapy Data". Journal of Cardiac Failure. 31 (9): 1490–1492. doi:10.1016/j.cardfail.2025.04.013. PMID 40412646 Check
|pmid=value (help). Retrieved 2025-12-03. - ↑ Bhojani, Naeem; Morris, Kathryn; White, Jenifer; Rojanasarot, Sirikan; Tran, Emma D.; Monga, Manoj (2025-09-16). "Post-operative infection with a single-use ureteroscope with real-time intrarenal pressure monitoring vs. all other single-use ureteroscopes". Journal of Endourology / Urology & Nephrology Clinics. 22 (10): 1135–1143. doi:10.1080/17434440.2025.2557403. PMID 40908713 Check
|pmid=value (help). Retrieved 2025-12-03. - ↑ Tao, Guoyu; He, Larry; Patel, Chirag; Papp, John; Barbee, Lindley A. (2025-09-18). "Assessing the need for creating ICD-10 codes to enhance monitoring of doxycycline postexposure prophylaxis prescriptions in the United States". Sexually Transmitted Diseases. doi:10.1097/OLQ.0000000000002245. PMID 40965055 Check
|pmid=value (help). Retrieved 2025-12-03. - ↑ Alipour, Ehsan; Gratzl, Samuel; Algohary, Ahmad; Lin, Hao; Bapat, Manoj; Do, Duy; Baker, Charlotte; Rodriguez, Tricia; Goodwin Cartwright, Brianna M.; Hadlock, Jennifer; Tarczy-Hornoch, Peter; Oka, Anand; Stucky, Nicholas L. (2025-10-03). "XComposition: multimodal deep learning model to measure body composition using chest radiographs and clinical data". Radiology Advances. 2 (5). doi:10.1093/radadv/umaf035. PMC 12560821 Check
|pmc=value (help). PMID 41164313 Check|pmid=value (help). Retrieved 2025-12-03. Unknown parameter|article-number=ignored (help)
This article "Truveta" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Truveta. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
